From: Human breast cancer associated fibroblasts exhibit subtype specific gene expression profiles
 |  | Overall | TNBC | ER+ | Her2+ | p-values | ||
---|---|---|---|---|---|---|---|---|
 |  |  |  |  |  | TNBC vs. ER+ | TNBC vs. Her2+ | ER+ vs. Her2+ |
n | Â | 20 | 7 | 7 | 6 | Â | Â | Â |
Age at diagnosis mean ± standard deviation | 52 ± 16 | 47 ± 14 | 59 ± 18 | 49 ± 16 | 0.21 | 0.83 | 0.33 | |
Ethnicity | Â | Â | Â | Â | Â | Â | Â | Â |
Caucasian | 10 | 3 | 5 | 2 | 0.59 | 1 | 0.56 | |
African American | 9 | 4 | 2 | 3 | ||||
Asian | 1 | 0 | 0 | 1 | Â | Â | Â | |
Invasive carcinoma histology | Â | Â | Â | Â | Â | Â | Â | |
 | ductal | 14 | 7 | 3 | 6 | 0.07 | 1 | 0.19 |
 | lobular | 6 | 0 | 4 | 0 | |||
Tumor size (cm) mean ± standard deviation | 4.8 ± 4.2 | 3.0 ± 1.1 | 4.9 ± 2.5 | 5.7 ± 7.4 | 0.06 | 0.35 | 0.81 | |
T1 | <2 cm | 4 | 1 | 1 | 2 | Â | Â | Â |
T2 | 2.1 - 5 cm | 10 | 6 | 2 | 2 | Â | Â | Â |
T3 | >5 cm | 6 | 0 | 4 | 2 | Â | Â | Â |
Tumor grade | Â | Â | Â | Â | Â | Â | Â | Â |
I | 0 | 0 | 0 | 0 | Â | Â | Â | |
II | 3 | 1 | 3 | 0 | 0.03 | 1 | 0.03 | |
III | 11 | 6 | 0 | 4 | ||||
not assessed | 6 | 0 | 4 | 2 | Â | Â | Â | |
No. of involved axilla node(s) mean ± standard deviation | 5.5 ± 7.8 | 4.1 ± 8.6 | 6.4 ± 8.4 | 6.0 ± 7.0 | 0.10 | 0.56 | 0.52 | |
 | 0 | 8 | 5 | 1 | 2 |  |  |  |
1-3 | 4 | 0 | 4 | 0 | Â | Â | Â | |
4-9 | 3 | 1 | 0 | 1 | Â | Â | Â | |
>9 | 4 | 1 | 2 | 2 | Â | Â | Â | |
not assessed | 1 | 0 | 0 | 1 | Â | Â | Â | |
Receptor status | Â | Â | Â | Â | Â | Â | Â | |
 | ER+ | 8 | 0 | 7 | 1 |  |  |  |
PR+ | 7 | 0 | 7 | 0 | Â | Â | Â | |
Her2+ | 6 | 0 | 0 | 6 | Â | Â | Â |